Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T12:46:32.128Z Has data issue: false hasContentIssue false

The use of poultry value chain mapping in developing HPAI control programmes

Published online by Cambridge University Press:  12 May 2009

A. MCLEOD*
Affiliation:
Food and Agriculture Organisation of the United Nations, Viale delle Terme di Caracalla, Rome 100153, Italy
M. KOBAYASHI
Affiliation:
Department of Resource Economics, University of Nevada, Reno, USA
J. GILMAN
Affiliation:
Emergency Centre for Transboundary Animal Diseases, Food and Agriculture Organisation of the United Nations, Jakarta, Indonesia
A. SIAGIAN
Affiliation:
Humanitarian Activities Unit, University of North Sumatra, Medan, Indonesia
M. YOUNG
Affiliation:
International Rural Poultry Centre, KYEEMA Foundation, Qld, Australia
*
Corresponding author: anni.mcleod@fao.org

Abstract

The continuing outbreaks of highly pathogenic avian influenza (HPAI) in Southeast Asia have been disastrous to the poultry industry in the region and have raised serious global public health concerns. Risk for animal and human health exists along the whole poultry value chain. The Food and Agricultural Organisation of the United Nations initiated a series of value chain studies in Asia and Africa during 2007 as a means to develop a better understanding of the trade flows, disease transmission mechanisms and possible entry points for intervention in various value chains. This paper outlines the methodology used to undertake these value chain studies, their use in developing policy and HPAI control measures that decrease animal and human health risks, and describes a value chain study in North Sumatra undertaken by FAO and the University of North Sumatra.

Information

Type
Review Article
Copyright
Copyright © Food and Agriculture Organization of the United Nations 2009
Figure 0

Figure 1 Duck value chain in Northern Sumatra.

Figure 1

Figure 2 Broiler chicken value chain in Northern Sumatra.

Figure 2

Table 1 Knowledge of clinical signs of HPAI by respondent.

Figure 3

Table 2 Distribution of respondents based on biosecurity application.

Figure 4

Table 3 Biosecurity practices at slaughter points.